Atossa Therapeutics (ATOS) Cash & Equivalents (2011 - 2026)
Atossa Therapeutics' Cash & Equivalents was $26.1 million in Q2 2026, down 54.9% from $57.86 million a year earlier and down 17.7% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Atossa Therapeutics came in at $41.3 million, down 41.9% from FY2024.
- Cash & Equivalents has now declined for four consecutive years, though with a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $71.08 million in FY2024 (-19.6%), $88.46 million in FY2023 (-20.2%), $110.89 million in FY2022 (-18.7%) and $136.38 million in FY2021 (+244.8%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q3 2020.
- Compared with a year earlier, Cash & Equivalents has declined for 18 straight quarters, with an average decline of 33.6% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2021 (growth of 244.8%); the worst was Q2 2026 (a decline of 54.9%).
- Per Business Quant data, ATOS's Cash & Equivalents in the three quarters before Q2 2026 was $31.72 million (Q1 2026), $41.3 million (Q4 2025) and $51.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Atossa Therapeutics | 23.35 Mn | 23.35 Mn | - | 26.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.10 Mn |
| Mar 31, 2026 | 31.72 Mn |
| Dec 31, 2025 | 41.30 Mn |
| Sep 30, 2025 | 51.85 Mn |
| Jun 30, 2025 | 57.86 Mn |
| Mar 31, 2025 | 65.12 Mn |
| Dec 31, 2024 | 71.08 Mn |
| Sep 30, 2024 | 74.77 Mn |
| Jun 30, 2024 | 79.53 Mn |
| Mar 31, 2024 | 83.96 Mn |
| Dec 31, 2023 | 88.46 Mn |
| Sep 30, 2023 | 94.03 Mn |
| Jun 30, 2023 | 99.39 Mn |
| Mar 31, 2023 | 103.87 Mn |
| Dec 31, 2022 | 110.89 Mn |
| Sep 30, 2022 | 117.37 Mn |
| Jun 30, 2022 | 125.54 Mn |
| Mar 31, 2022 | 131.49 Mn |
| Dec 31, 2021 | 136.38 Mn |
| Sep 30, 2021 | 140.04 Mn |
API Access
Atossa Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();